uniQure N.V. (QURE) — research page
US · us-cm-kg/NASDAQ/QURE · as of 2026-11-08
Identity and listing
The issuer is uniQure N.V., listed on NASDAQ under ticker QURE, with ISIN USN900641010. The LEI is not on the record. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its segment and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | uniQure N.V. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | QURE | source · 2026-11-08 |
| ISIN | USN900641010 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 114 filings across 51 filing days in the twelve months to 2026-11-08. Of these, 52 are regulatory filings, 36 are directors' dealings, 10 are corporate news, 10 are results, 3 are AGM/EGM notices, 2 are prospectuses and 1 is a director change. The median gap between filing days is 3.5 days. The latest filing is dated 2026-11-06, is a regulatory filing, and is 2 days before the record date. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 6.0 days, with a median of 63.0 filings and a median latency of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 114 | 3.5 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | regulatory_filing | 144 | 144 |
| 2026-11-04 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-04 | results | 8-K | 8-K — FORM 8-K (items 2.02,9.01) |
| 2026-11-03 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
| 2026-11-02 | corporate_news | 8-K | 8-K — FORM 8-K (items 7.01,8.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, because the latest annual report cover carries no auditor name tag. Its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, and the segment move is not on the record. The halt flag shows the issuer is listed and not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter was dated 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 14 research houses: Barclays, Cantor Fitzgerald, Goldman Sachs, Guggenheim, H.C. Wainwright, Kempen, Leerink Partners, RBC Capital, Stifel, TD Cowen, UBS, Wells Fargo, William Blair and Wolfe Research.
| research house | analyst | source · read date |
|---|---|---|
| Barclays | Eliana Merle | issuer page · 2026-11-11 |
| Cantor Fitzgerald | Kristen Kluska | issuer page · 2026-11-11 |
| Goldman Sachs | Salveen Richter, CFA | issuer page · 2026-11-11 |
| Guggenheim | Debjit Chattopadhyay | issuer page · 2026-11-11 |
| H.C. Wainwright | Patrick Trucchio | issuer page · 2026-11-11 |
| Kempen | Sushila Hernandez | issuer page · 2026-11-11 |
| Leerink Partners | Joseph Schwartz, MBA | issuer page · 2026-11-11 |
| RBC Capital | Luca Issi | issuer page · 2026-11-11 |
| Stifel | Paul Matteis | issuer page · 2026-11-11 |
| TD Cowen | Joseph Thome, Ph.D. | issuer page · 2026-11-11 |
| UBS | Joon Lee | issuer page · 2026-11-11 |
| Wells Fargo | Yanan Zhu, Ph.D. | issuer page · 2026-11-11 |
| William Blair | Lachlan Hanbury-Brown | issuer page · 2026-11-11 |
| Wolfe Research | Rudy Li | issuer page · 2026-11-11 |
Open research
No openly published research notes were found.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001590560.json (identity.name)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/QURE (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.uniqure.com/investors-media/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/QURE (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"USN900641010"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9e2618e07c53d615.